After primary breast cancer was treated with doxorubicin, but not cisplatin, CAFs in the lung secrete complement factors such as Ca3 and Ca5 to recruit myeloid-derived suppressive cells to modulate the immunosuppressive metastatic niche (the soil) for circulating tumor cells (the seedlings) [43]. This evidence concerns the gene CA3 and neoplasm.